INT158033

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.07
First Reported 2009
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 5
Disease Relevance 3.11
Pain Relevance 0.17

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

CEACAMP1 (Homo sapiens)
Pain Link Frequency Relevance Heat
ischemia 120 83.60 Quite High
Pain 2 10.00 Low Low
imagery 63 5.00 Very Low Very Low Very Low
Angina 27 5.00 Very Low Very Low Very Low
depression 9 5.00 Very Low Very Low Very Low
Inflammation 3 5.00 Very Low Very Low Very Low
beta blocker 3 5.00 Very Low Very Low Very Low
Arthritis 3 5.00 Very Low Very Low Very Low
trigger zone 3 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Acute Coronary Syndrome 57 99.84 Very High Very High Very High
Coronary Artery Disease 180 97.16 Very High Very High Very High
Myocardial Infarction 141 91.92 High High
Death 27 85.28 High High
Cv Unclassified Under Development 63 83.60 Quite High
Pathologic Constriction 9 82.72 Quite High
Diabetes Mellitus 4 50.00 Quite Low
Heart Disease 15 23.44 Low Low
Cv General 3 Under Development 24 5.00 Very Low Very Low Very Low
Ventricular Tachycardia 21 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Overall, CGM was acceptable and feasible.
Gene_expression (acceptable) of CGM
1) Confidence 0.07 Published 2009 Journal Diabetes Technol. Ther. Section Body Doc Link 19216684 Disease Relevance 0 Pain Relevance 0
Acceptability data included CGM satisfaction and wearing difficulties.
Gene_expression (satisfaction) of CGM
2) Confidence 0.07 Published 2009 Journal Diabetes Technol. Ther. Section Body Doc Link 19216684 Disease Relevance 0 Pain Relevance 0
Thus far, the advantages of VCG and CGM over standard electrocardiographic methods in ACS, prognostic evaluation and risk stratification have not been proven in larger studies.
Gene_expression (methods) of CGM associated with acute coronary syndrome
3) Confidence 0.04 Published 2010 Journal GMS German Medical Science Section Body Doc Link PMC2975259 Disease Relevance 1.22 Pain Relevance 0.04
CGM’s sensitivity to detect NSTE-ACS patients was 73%.
Gene_expression (detect) of CGM associated with acute coronary syndrome
4) Confidence 0.04 Published 2010 Journal GMS German Medical Science Section Body Doc Link PMC2975259 Disease Relevance 1.17 Pain Relevance 0.03
CGM was introduced by Sanz [48] and further developed and tested in patients with stable CAD by Schuepbach [49].
Gene_expression (introduced) of CGM associated with coronary artery disease
5) Confidence 0.04 Published 2010 Journal GMS German Medical Science Section Body Doc Link PMC2975259 Disease Relevance 0.72 Pain Relevance 0.10

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox